by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
News Bulletin : ADA News Bulletin August 2010
Panadeine Extra contains paracetamol 500 mg and codeine phosphate 15 mg. Use: For temporary relief from moderate to severe pain. Contraindications: Hypersensitivity to any ingredient in the product; children under 12 years. Precautions: CNS, respiratory depression; high doses, prolonged use; renal, hepatic impairment; poor CYP2D6 function; pregnancy & lactation. Adverse reactions: Dependence; Impairment of mental & physical abilities; nausea, vomiting, constipation; dizziness, drowsiness. Interactions: Anticoagulants; sedatives, tranquillisers; drugs affecting gastric emptying; chloramphenicol; hepatic enzyme inducers; CYP2D6 inhibitors. Dosage: Adults and children 12 years and over: 2 Caplets every 4--6 hours orally with water; (maximum 8 caplets in 24hrs). Please review full Production Information (PI) before recommending. The full PI is available from GlaxoSmithKline Consumer Healthcare on request (FREECALL 1800 028 533). Panadeine , Caplet and the Panadeine Vibration are trade marks of the GlaxoSmithKline group of companies. GlaxoSmithKline Consumer Healthcare. 82 Hughes Avenue, Ermington, NSW 2115. 1800 028 533. GLA0020/B/ADA
ADA News Bulletin September 2010